Anton Health’s Post

We just ran across an interesting article that spotlights four key takeaways from the Asembia Specialty Pharmacy Summit, which was held earlier this year. The article is from the perspective of four lawyers who attended the Summit. Their perspectives and conclusions merit consideration by all specialty pharmacies in their strategic planning, as they are perhaps better positioned to see the forest as well as all the trees. #specialtypharmacy #marketaccess

It's day two of the DiversifyRx Pharmacy Profit Summit here in Dallas! We can't wait to connect with even more independent pharmacies and continue the great dialog around increasing pharmacy profitability today! Be sure to swing by our booth (#203) and learn how BestRx can help your pharmacy grow. #BestRxPharmacySoftware #PharmacySolutions #DiversifyRx #PharmacyProfitSummit

OUT NOW 👉 https://bit.ly/4b4YLbE Hutchings 2024 UK Pharmacy Market Update As the first month of 2024 draws to a close, what are your plans for this year? If you're thinking of selling your business or buying your first, stay abreast of the current market, trends, and predictions with Paul Steet's 2024 UK Pharmacy Market Update. #pharmacysales NPA - National Pharmacy Association

Navigating the Evolving Landscape of the U.S. Compounding Pharmacies Market As the healthcare industry shifts toward personalized treatment solutions, the competition in the U.S. compounding pharmacies market is intensifying. With players like Avella Specialty Pharmacy, CAPS, and Fagron leading the way, these pharmacies are rising to meet the demand for customized medications tailored to individual needs. 503A pharmacies hold the largest share of the U.S. compounding pharmacies market and are projected to grow at an impressive CAGR of 4.30%.  Know More! https://lnkd.in/dz47FrCr #ariztonresearchreveals #marketresearch #marketinsights #marketopportunities #usmarket #compoundingpharmacymarket #healthcare  Key Players:  Avella Specialty Pharmacy | Fagron | Fresenius Kabi | Pencol Specialty Pharmacy | Austin Compounding Pharmacy | Charles River Laboratories | Dougherty Pharmacy Inc

340B Hospitals Should Consider Internal Pharmacies, Selective Contracting, Says Consulting Group - https://lnkd.in/e6Y6hv8e Hospitals in the 340B program should respond to increasing drugmaker contract pharmacy restrictions by opening their own pharmacies or selectively [...] #340B

📢 Don't miss out on our upcoming webinar dedicated to mastering pharmacy cost management! The ongoing struggle for cost transparency within the PBM industry has significantly impacted the spending and utilization patterns of our valued clients. Join us as Ginny Crisp, our esteemed pharmacy consultant, shares her expertise in this crucial area. You won't want to miss the valuable insights she has to offer! Secure your spot by registering through the link below. 🚀

Mark your calendars for this informative webinar on “Mastering Pharmacy Costs” you won’t want to miss it!

Join our webinar on "Mastering Pharmacy Costs: The Power of Strategic Contracts.” We’ll discuss the intricacies of strategic pharmacy contracts and give you the tools and knowledge to help you take control of your pharmacy costs. https://hubs.ly/Q02rvfB60

Are your pharmacy costs skyrocketing? We have a solution for you. Join our webinar, April 24th at 2:00pm EST for tools and strategies to take control of these costs. Click the link below to sign up!

Are you going to Asembia? Book some time with D2 to learn how you can steamline the Prior Authorization process and enhance patient communication via digital technologies.